Mundle, Rhea http://orcid.org/0000-0001-7430-1998
Afenya, Evans
Agarwal, Neeraj http://orcid.org/0000-0003-1076-0428
Article History
Received: 10 November 2020
Revised: 4 February 2021
Accepted: 18 February 2021
First Online: 9 March 2021
Compliance with ethical standards
:
: This review study was an independent collaboration and did not receive any funding. Author disclosures: Neeraj Agarwal: disclosure as follows, Consultancy to: Astellas, Astra Zeneca, Bayer, Bristol Myers Squibb, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genentech, Janssen, Merck, Nektar, Novartis, Pfizer, Pharmacyclics, and Seattle Genetics. Research funding to Dr. Agarwal’s institution: Astra Zeneca, Bavarian Nordic, Bayer, Bristol Myers Squibb, Calithera, Celldex, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Genentech, Glaxo Smith Kline, Immunomedics, Janssen, Medivation, Merck, Nektar, New Link Genetics, Novartis, Pfizer, Prometheus, Rexahn, Roche, Sanofi, Seattle Genetics, Takeda, and Tracon. RM and EA declare no competing interests.